Literature DB >> 34349398

A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Masoud Mahdinejad-Yazdi1, Mohammad Reza Sobhan1, Seyed Alireza Dastgheib2, Reza Bahrami3, Seyed Hossein Shaker4, Hamid Mirjalili5, Jalal Sadeghizadeh-Yazdi6, Masoud Zare-Shehneh7, Hossein Neamatzadeh7,8.   

Abstract

OBJECTIVE: We performed a meta-analysis of all eligible studies on the association of TNF-α -308G>A polymorphism with risk of Ankylosing spondylitis (AS).
METHODS: A comprehensive literature research was performed in online databases.
RESULTS: A total of 28 studies with 4489 cases and 5919 controls were included. Pooled ORs showed a significant association between TNF-α -308G>A polymorphism and risk of AS. Moreover, stratified analysis by ethnicity showed a significant association between TNF-α -308G>A polymorphism and AS risk in Asians, Caucasians and Mixed populations, but not in Chinese population.
CONCLUSION: This meta-analysis suggested that the TNF-α -308G>A polymorphism was associated with AS risk.
© 2021 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Ethnicity; Joints inflammation; Meta-analysis; Polymorphism; TNF-α

Year:  2021        PMID: 34349398      PMCID: PMC8319454          DOI: 10.1016/j.jor.2021.07.015

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  46 in total

Review 1.  Global prevalence of ankylosing spondylitis.

Authors:  Linda E Dean; Gareth T Jones; Alan G MacDonald; Christina Downham; Roger D Sturrock; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2013-12-09       Impact factor: 7.580

2.  TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients.

Authors:  S González; J C Torre-Alonso; J Martínez-Borra; J A Fernández Sánchez; A López-Vazquez; A Rodríguez Pérez; C López-Larrea
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

3.  Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis.

Authors:  Gilberto Vargas-Alarcón; Julio Casasola-Vargas; José Manuel Rodríguez-Pérez; Gabriela Huerta-Sil; Nonanzit Pérez-Hernández; John Londoño; Cesar Pacheco-Tena; Mario H Cardiel; Julio Granados; Rubén Burgos-Vargas
Journal:  Hum Immunol       Date:  2006-08-22       Impact factor: 2.850

4.  Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population.

Authors:  Naiwen Hu; Yazhou Cui; Qingrui Yang; Liya Wang; Xinglin Yang; Hongzhi Xu
Journal:  Rheumatol Int       Date:  2017-12-11       Impact factor: 2.631

5.  The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bo Ma; Bing Yang; Hainiu Guo; Yihong Wang; Dayi Zhang; Yuan Zhang; Zhengquan Xiao
Journal:  Hum Immunol       Date:  2013-07-02       Impact factor: 2.850

Review 6.  Epidemiology of spondyloarthritis: a review.

Authors:  Gunnstein Bakland; Hans C Nossent
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

7.  Bilateral Synovial Knee Chondromatosis in a Patient with Rheumatoid Arthritis: Case-report and Literature Review.

Authors:  M N Tahmasebi; Kaveh Bashti; Mr Sobhan; Gh Ghorbani
Journal:  Arch Bone Jt Surg       Date:  2014-10-15

8.  Association of TNF-α -308G>A Polymorphism with Susceptibility to Cervical Cancer and Breast Cancer - a Systematic Review and Meta-analysis.

Authors:  Meraj Farbod; Mojgan Zarchi Karimi; Naeimeh Heiranizadeh; Neda Shalamzari Seifi; Javad Bafghi Mohammad Akbarian; Hossein Mohammad Jarahzadeh; Hossein Neamatzadeh
Journal:  Klin Onkol       Date:  2019

Review 9.  Ankylosing spondylitis.

Authors:  Jürgen Braun; Joachim Sieper
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

10.  Identification of ANKDD1B variants in an ankylosing spondylitis pedigree and a sporadic patient.

Authors:  Zhiping Tan; Hui Zeng; Zhaofa Xu; Qi Tian; Xiaoyang Gao; Chuanman Zhou; Yu Zheng; Jian Wang; Guanghui Ling; Bing Wang; Yifeng Yang; Long Ma
Journal:  BMC Med Genet       Date:  2018-07-05       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.